What it's for (Indications)
- This medicine is indicated in infected inflammatory conditions, rheumatology (disorders of muscles and joints), pulmonary disease (lung disease), and allergic and asthmatic conditions.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | For ophthalmic administration of dexamethasone and sulphacetamide combination preparations, the precise dosage regimen is highly dependent on the specific formulation (e.g., ophthalmic solution, suspension, or ointment), the severity of the ocular condition, and the treating physician's clinical judgment. A common starting regimen for ophthalmic drops or suspensions might involve instilling one or two drops into the conjunctival sac of the affected eye(s) every four to six hours, which may be adjusted to every two hours for severe cases during the initial treatment phase. As the inflammatory response subsides and clinical improvement is noted, the frequency is typically reduced gradually over several days or weeks to minimize potential side effects and prevent rebound inflammation. Ointment formulations are often applied as a small ribbon (approximately 1/2 inch) into the conjunctival sac, usually one to three times daily, depending on the indication. It is crucial for patients to strictly adhere to the prescribed dosage, frequency, and duration of treatment, as prolonged or improper use of corticosteroids can lead to elevated intraocular pressure, glaucoma, cataract formation, or secondary infections. Patients should be instructed on proper administration techniques, including shaking suspensions well before use, avoiding contamination of the dropper/tube tip, and not discontinuing treatment abruptly without medical advice. This medication is for topical ocular use only and should not be injected or taken orally. |
Safety & Warnings
Common Side Effects
- Patients using this medication may at times experience corneal thinning, cataract, fungal infection, and a rise in intraocular (eye) pressure.
- If any of these symptoms persist for a long period, consult a doctor immediately.
Serious Warnings
- Black Box Warning: None
- Pregnant females are advised to consult their doctors before using this medicine.
- The effect is undetermined in lactating females; consult a doctor for further advice.
- It is safe to drive after taking this medicine.
- Caution is advised for patients with liver or kidney impairment; consult a doctor before taking this medicine.
- Exercise extreme caution in patients with chickenpox, measles, renal impairment, hepatic failure, myasthenia gravis (neuromuscular disease), epilepsy (seizures), and congestive heart failure.
- Withdrawal of the medication should be gradual.
How it Works (Mechanism of Action)
The therapeutic efficacy of the dexamethasone and sulphacetamide combination arises from the distinct yet complementary pharmacological actions of its two active components, targeting both inflammation and bacterial proliferation. Dexamethasone, a potent synthetic glucocorticoid, exerts its anti-inflammatory and immunosuppressive effects primarily by binding to intracellular glucocorticoid receptors. This binding leads to the translocation of the receptor-ligand complex into the cell nucleus, where it modulates gene expression. Specifically, it upregulates the synthesis of anti-inflammatory proteins, such as lipocortin-1 (annexin A1), which inhibits phospholipase A2, thereby reducing the production of prostaglandins and leukotrienes from arachidonic acid. Concurrently, it downregulates the expression of pro-inflammatory genes, including those encoding cytokines (e.e., TNF-α, IL-1, IL-6), chemokines, and adhesion molecules. Dexamethasone also stabilizes lysosomal membranes, reduces capillary permeability, and inhibits the migration and activity of inflammatory cells (e.g., neutrophils, macrophages) to the site of injury, thereby diminishing swelling, redness, pain, and other signs of inflammation. Sulphacetamide, a bacteriostatic sulfonamide antibiotic, exerts its antimicrobial action by competitively inhibiting dihydropteroate synthase, an enzyme crucial for the synthesis of dihydrofolic acid from para-aminobenzoic acid (PABA) in susceptible bacteria. Since bacteria require dihydrofolic acid to synthesize tetrahydrofolic acid, a vital cofactor for the synthesis of purine bases, pyrimidine, and methionine, sulphacetamide effectively blocks bacterial growth and proliferation. This dual mechanism of action provides comprehensive treatment for responsive ocular conditions characterized by both inflammation and bacterial infection or the risk thereof.